Browse medicines
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 1–4 of 4 records
Elasomeran (Spikevax)
RNA medicine or vaccineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
COVID-19 prevention in older adults and people at higher risk
mRNA-1345 (mResvia)
RNA medicine or vaccineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
RSV lung infection prevention in older and higher-risk adults
Tozinameran (Comirnaty)
RNA medicine or vaccineApproved in the United States (FDA)Detailed recordUse listed on the medicine record
COVID-19 prevention in older adults and people at higher risk
COVID-19 Vaccine, mRNA (Spikevax / Comirnaty / Mnexspike)
RNA medicine or vaccineLaboratory or animal-stage researchExpanded record